Concepts (216)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nitric Oxide | 25 | 2023 | 316 | 4.270 |
Why?
|
| Kidney | 21 | 2023 | 337 | 3.900 |
Why?
|
| PPAR alpha | 8 | 2018 | 42 | 2.880 |
Why?
|
| Hypertension | 10 | 2023 | 796 | 1.980 |
Why?
|
| Sodium Chloride, Dietary | 5 | 2018 | 41 | 1.700 |
Why?
|
| Cytochrome P-450 Enzyme System | 9 | 2010 | 92 | 1.580 |
Why?
|
| Blood Pressure | 16 | 2022 | 646 | 1.410 |
Why?
|
| Rats | 32 | 2023 | 3483 | 1.340 |
Why?
|
| Renal Circulation | 9 | 2022 | 21 | 1.200 |
Why?
|
| Fumarates | 2 | 2023 | 11 | 1.130 |
Why?
|
| Endothelin-1 | 9 | 2010 | 55 | 1.090 |
Why?
|
| Rats, Sprague-Dawley | 26 | 2016 | 1618 | 1.090 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2018 | 84 | 1.030 |
Why?
|
| Animals | 41 | 2023 | 15081 | 0.960 |
Why?
|
| Ureteral Obstruction | 1 | 2023 | 17 | 0.870 |
Why?
|
| Kidney Diseases | 2 | 2023 | 167 | 0.850 |
Why?
|
| Cell Adhesion Molecules | 1 | 2023 | 75 | 0.850 |
Why?
|
| Vasodilation | 6 | 2007 | 65 | 0.840 |
Why?
|
| NG-Nitroarginine Methyl Ester | 8 | 2022 | 36 | 0.820 |
Why?
|
| Arachidonic Acid | 6 | 2003 | 35 | 0.770 |
Why?
|
| Reperfusion Injury | 2 | 2016 | 57 | 0.760 |
Why?
|
| Vasoconstriction | 7 | 2010 | 42 | 0.660 |
Why?
|
| Natriuresis | 5 | 2018 | 11 | 0.660 |
Why?
|
| Kidney Medulla | 3 | 2018 | 6 | 0.640 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 2018 | 2 | 0.640 |
Why?
|
| Hydroxyeicosatetraenoic Acids | 7 | 2010 | 9 | 0.590 |
Why?
|
| Neprilysin | 2 | 2010 | 7 | 0.590 |
Why?
|
| Protein Kinase C | 3 | 2010 | 120 | 0.580 |
Why?
|
| Glomerular Filtration Rate | 2 | 2016 | 139 | 0.560 |
Why?
|
| Angiotensin II | 5 | 2010 | 97 | 0.530 |
Why?
|
| Amiloride | 2 | 2022 | 18 | 0.530 |
Why?
|
| Sodium | 4 | 2022 | 103 | 0.510 |
Why?
|
| Male | 31 | 2018 | 20025 | 0.510 |
Why?
|
| Aorta | 3 | 2007 | 167 | 0.510 |
Why?
|
| Enzyme Inhibitors | 6 | 2010 | 433 | 0.490 |
Why?
|
| Kidney Glomerulus | 3 | 2007 | 84 | 0.480 |
Why?
|
| Nitric Oxide Synthase | 5 | 2018 | 128 | 0.480 |
Why?
|
| Free Radicals | 5 | 2010 | 74 | 0.470 |
Why?
|
| Receptors, Purinergic P1 | 1 | 2013 | 7 | 0.470 |
Why?
|
| PPAR gamma | 4 | 2010 | 53 | 0.460 |
Why?
|
| Signal Transduction | 5 | 2023 | 1908 | 0.460 |
Why?
|
| Malates | 2 | 2023 | 3 | 0.440 |
Why?
|
| Neovascularization, Physiologic | 1 | 2013 | 73 | 0.440 |
Why?
|
| Clofibrate | 6 | 2010 | 13 | 0.440 |
Why?
|
| Kidney Tubules, Proximal | 2 | 2004 | 28 | 0.430 |
Why?
|
| 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | 4 | 2010 | 11 | 0.400 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2011 | 10 | 0.400 |
Why?
|
| Peroxisome Proliferator-Activated Receptors | 1 | 2011 | 13 | 0.400 |
Why?
|
| Desoxycorticosterone | 4 | 2021 | 9 | 0.370 |
Why?
|
| Mice, Knockout | 5 | 2018 | 933 | 0.370 |
Why?
|
| Hemodynamics | 3 | 2022 | 91 | 0.340 |
Why?
|
| Receptor, Angiotensin, Type 1 | 2 | 2008 | 23 | 0.330 |
Why?
|
| Acetylcholine | 3 | 2006 | 73 | 0.330 |
Why?
|
| Indans | 2 | 2010 | 13 | 0.320 |
Why?
|
| Propionates | 2 | 2010 | 26 | 0.320 |
Why?
|
| Oxidative Stress | 3 | 2013 | 938 | 0.320 |
Why?
|
| Receptor, Angiotensin, Type 2 | 1 | 2008 | 6 | 0.320 |
Why?
|
| Thiazides | 1 | 2008 | 2 | 0.310 |
Why?
|
| Hypertension, Renal | 1 | 2008 | 16 | 0.310 |
Why?
|
| Endothelium, Vascular | 1 | 2010 | 237 | 0.310 |
Why?
|
| Cerebral Cortex | 1 | 2010 | 290 | 0.310 |
Why?
|
| RNA, Small Interfering | 1 | 2009 | 409 | 0.300 |
Why?
|
| Glycerol | 3 | 2007 | 28 | 0.300 |
Why?
|
| Proteinuria | 4 | 2013 | 50 | 0.290 |
Why?
|
| Isoproterenol | 2 | 2004 | 36 | 0.290 |
Why?
|
| Xanthine Oxidase | 1 | 2006 | 8 | 0.290 |
Why?
|
| Cyclosporine | 1 | 2006 | 27 | 0.280 |
Why?
|
| Vasodilator Agents | 3 | 2007 | 56 | 0.280 |
Why?
|
| Antihypertensive Agents | 3 | 2021 | 284 | 0.280 |
Why?
|
| Kidney Tubules | 2 | 2003 | 33 | 0.270 |
Why?
|
| Microsomes | 4 | 2010 | 52 | 0.270 |
Why?
|
| Oxygenases | 2 | 2003 | 6 | 0.270 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2006 | 187 | 0.260 |
Why?
|
| Dinoprostone | 1 | 2005 | 63 | 0.250 |
Why?
|
| Models, Animal | 4 | 2008 | 134 | 0.250 |
Why?
|
| Aging | 2 | 2006 | 664 | 0.250 |
Why?
|
| Nitric Oxide Synthase Type III | 4 | 2010 | 67 | 0.240 |
Why?
|
| Fumarate Hydratase | 1 | 2023 | 1 | 0.240 |
Why?
|
| Thromboxane A2 | 3 | 2010 | 20 | 0.230 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2004 | 59 | 0.230 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2005 | 1039 | 0.230 |
Why?
|
| 8,11,14-Eicosatrienoic Acid | 1 | 2003 | 4 | 0.230 |
Why?
|
| Endothelial Cells | 1 | 2006 | 308 | 0.230 |
Why?
|
| Antioxidants | 2 | 2007 | 416 | 0.220 |
Why?
|
| Heme Oxygenase (Decyclizing) | 2 | 2018 | 30 | 0.220 |
Why?
|
| Cyclic AMP | 1 | 2003 | 131 | 0.220 |
Why?
|
| NADPH-Ferrihemoprotein Reductase | 1 | 2002 | 9 | 0.220 |
Why?
|
| Mice | 5 | 2018 | 5913 | 0.210 |
Why?
|
| Mixed Function Oxygenases | 1 | 2002 | 34 | 0.210 |
Why?
|
| Phenylephrine | 3 | 2007 | 36 | 0.210 |
Why?
|
| Pergolide | 1 | 2002 | 2 | 0.210 |
Why?
|
| Fibrosis | 1 | 2023 | 159 | 0.210 |
Why?
|
| Ascorbic Acid | 4 | 2007 | 66 | 0.200 |
Why?
|
| Down-Regulation | 2 | 2018 | 435 | 0.190 |
Why?
|
| Acetates | 1 | 2021 | 21 | 0.190 |
Why?
|
| Pyrimidines | 2 | 2013 | 118 | 0.180 |
Why?
|
| Female | 6 | 2018 | 20969 | 0.170 |
Why?
|
| Sodium Chloride | 2 | 2010 | 55 | 0.170 |
Why?
|
| Transcription Factors | 1 | 2004 | 681 | 0.170 |
Why?
|
| Brain | 1 | 2006 | 1346 | 0.160 |
Why?
|
| Miconazole | 2 | 2013 | 4 | 0.160 |
Why?
|
| Behavioral Research | 1 | 2019 | 39 | 0.160 |
Why?
|
| Lipid Peroxides | 2 | 2010 | 17 | 0.160 |
Why?
|
| Diuresis | 1 | 2018 | 7 | 0.160 |
Why?
|
| Kidney Cortex | 1 | 2018 | 8 | 0.160 |
Why?
|
| Minority Health | 1 | 2019 | 88 | 0.160 |
Why?
|
| Vasoconstrictor Agents | 2 | 2010 | 41 | 0.160 |
Why?
|
| Naphthalenes | 2 | 2010 | 38 | 0.150 |
Why?
|
| Bradykinin | 2 | 2007 | 22 | 0.150 |
Why?
|
| Nitrates | 2 | 2010 | 40 | 0.150 |
Why?
|
| Sirolimus | 1 | 2016 | 60 | 0.140 |
Why?
|
| Thiazolidinediones | 2 | 2007 | 50 | 0.140 |
Why?
|
| Nitroprusside | 2 | 2006 | 15 | 0.130 |
Why?
|
| Autophagy | 1 | 2016 | 116 | 0.130 |
Why?
|
| Kidney Function Tests | 2 | 2008 | 29 | 0.120 |
Why?
|
| Time Factors | 2 | 2013 | 1742 | 0.120 |
Why?
|
| Biomedical Research | 1 | 2019 | 400 | 0.120 |
Why?
|
| Adenosine-5'-(N-ethylcarboxamide) | 1 | 2013 | 1 | 0.120 |
Why?
|
| Receptor, Adenosine A2B | 1 | 2013 | 4 | 0.120 |
Why?
|
| Minority Groups | 1 | 2019 | 596 | 0.120 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2013 | 20 | 0.120 |
Why?
|
| Purines | 1 | 2013 | 38 | 0.110 |
Why?
|
| Osteopontin | 1 | 2013 | 36 | 0.110 |
Why?
|
| Collagen Type IV | 1 | 2013 | 48 | 0.110 |
Why?
|
| Nitrites | 2 | 2010 | 46 | 0.110 |
Why?
|
| Epoxy Compounds | 2 | 2003 | 15 | 0.110 |
Why?
|
| Microscopy, Fluorescence | 1 | 2013 | 252 | 0.110 |
Why?
|
| Biological Transport | 2 | 2004 | 185 | 0.110 |
Why?
|
| Protein Structure, Tertiary | 1 | 2013 | 408 | 0.110 |
Why?
|
| Creatinine | 2 | 2010 | 103 | 0.100 |
Why?
|
| Zebrafish | 1 | 2013 | 128 | 0.100 |
Why?
|
| Indoles | 1 | 2013 | 158 | 0.100 |
Why?
|
| Myocardium | 1 | 2013 | 235 | 0.100 |
Why?
|
| Ventricular Remodeling | 1 | 2011 | 57 | 0.090 |
Why?
|
| Gene Expression Regulation | 2 | 2013 | 1015 | 0.090 |
Why?
|
| Sus scrofa | 1 | 2010 | 19 | 0.090 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2010 | 41 | 0.090 |
Why?
|
| Inflammation Mediators | 1 | 2011 | 123 | 0.090 |
Why?
|
| Gene Deletion | 1 | 2010 | 166 | 0.090 |
Why?
|
| Microvessels | 1 | 2010 | 28 | 0.090 |
Why?
|
| G-Protein-Coupled Receptor Kinase 2 | 1 | 2009 | 6 | 0.090 |
Why?
|
| Administration, Oral | 1 | 2010 | 224 | 0.080 |
Why?
|
| Plasmids | 1 | 2009 | 246 | 0.080 |
Why?
|
| Cardiovascular Agents | 1 | 2008 | 20 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 1 | 2009 | 448 | 0.080 |
Why?
|
| Diuretics | 1 | 2008 | 52 | 0.080 |
Why?
|
| Organ Size | 1 | 2008 | 157 | 0.080 |
Why?
|
| Base Sequence | 1 | 2009 | 997 | 0.070 |
Why?
|
| Humans | 4 | 2023 | 37093 | 0.070 |
Why?
|
| Drug Resistance | 1 | 2008 | 99 | 0.070 |
Why?
|
| Microcirculation | 1 | 2006 | 37 | 0.070 |
Why?
|
| Amidines | 1 | 2006 | 3 | 0.070 |
Why?
|
| Muscle Tonus | 1 | 2006 | 6 | 0.070 |
Why?
|
| Muscle Relaxants, Central | 1 | 2006 | 5 | 0.070 |
Why?
|
| Inflammation | 1 | 2011 | 618 | 0.070 |
Why?
|
| Molecular Sequence Data | 1 | 2009 | 1568 | 0.070 |
Why?
|
| rho-Associated Kinases | 1 | 2006 | 31 | 0.070 |
Why?
|
| Arginine | 1 | 2006 | 73 | 0.070 |
Why?
|
| Swine | 1 | 2006 | 184 | 0.070 |
Why?
|
| GTP-Binding Proteins | 1 | 2006 | 60 | 0.070 |
Why?
|
| Nitriles | 1 | 2006 | 69 | 0.070 |
Why?
|
| Biological Factors | 1 | 2005 | 6 | 0.070 |
Why?
|
| Triazoles | 1 | 2006 | 86 | 0.070 |
Why?
|
| Amides | 1 | 2006 | 68 | 0.070 |
Why?
|
| Cells, Cultured | 1 | 2010 | 1518 | 0.070 |
Why?
|
| Pyridines | 1 | 2006 | 116 | 0.070 |
Why?
|
| Body Weight | 1 | 2008 | 434 | 0.070 |
Why?
|
| Systole | 1 | 2005 | 61 | 0.070 |
Why?
|
| Hydrazines | 1 | 2005 | 21 | 0.060 |
Why?
|
| Indomethacin | 1 | 2005 | 28 | 0.060 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2005 | 34 | 0.060 |
Why?
|
| Xanthine | 1 | 2004 | 3 | 0.060 |
Why?
|
| Cerebrovascular Circulation | 1 | 2005 | 70 | 0.060 |
Why?
|
| Acyl-CoA Dehydrogenase | 1 | 2004 | 5 | 0.060 |
Why?
|
| Splanchnic Circulation | 1 | 2003 | 4 | 0.060 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2004 | 28 | 0.060 |
Why?
|
| Mesenteric Arteries | 1 | 2003 | 20 | 0.060 |
Why?
|
| Aorta, Thoracic | 1 | 2003 | 28 | 0.060 |
Why?
|
| Liver Cirrhosis | 1 | 2003 | 52 | 0.060 |
Why?
|
| Prostaglandins | 1 | 2003 | 27 | 0.060 |
Why?
|
| Analysis of Variance | 1 | 2004 | 550 | 0.060 |
Why?
|
| Glucose | 1 | 2004 | 230 | 0.050 |
Why?
|
| Obesity | 1 | 2011 | 1067 | 0.050 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2003 | 168 | 0.050 |
Why?
|
| Rubidium Radioisotopes | 1 | 2002 | 2 | 0.050 |
Why?
|
| Receptor, Endothelin A | 1 | 2002 | 3 | 0.050 |
Why?
|
| Receptors, Endothelin | 1 | 2002 | 7 | 0.050 |
Why?
|
| Superoxides | 1 | 2002 | 53 | 0.050 |
Why?
|
| Dopamine Agonists | 1 | 2002 | 30 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 1 | 2006 | 1609 | 0.050 |
Why?
|
| Urodynamics | 1 | 2000 | 4 | 0.050 |
Why?
|
| Kinetics | 1 | 2002 | 708 | 0.050 |
Why?
|
| Homeostasis | 1 | 2000 | 188 | 0.040 |
Why?
|
| Antifungal Agents | 1 | 2000 | 148 | 0.040 |
Why?
|
| Research Support as Topic | 1 | 2019 | 80 | 0.040 |
Why?
|
| Research Personnel | 1 | 2019 | 155 | 0.040 |
Why?
|
| Cultural Diversity | 1 | 2019 | 169 | 0.040 |
Why?
|
| Reactive Oxygen Species | 2 | 2010 | 461 | 0.030 |
Why?
|
| Health Status Disparities | 1 | 2019 | 642 | 0.030 |
Why?
|
| Reactive Nitrogen Species | 1 | 2010 | 9 | 0.020 |
Why?
|
| Glomerular Basement Membrane | 1 | 2010 | 9 | 0.020 |
Why?
|
| Rats, Inbred SHR | 1 | 2009 | 32 | 0.020 |
Why?
|
| United States | 1 | 2019 | 4223 | 0.020 |
Why?
|
| Receptors, Thromboxane A2, Prostaglandin H2 | 1 | 2007 | 2 | 0.020 |
Why?
|
| Renal Artery | 1 | 2007 | 7 | 0.020 |
Why?
|
| Thromboxane B2 | 1 | 2007 | 9 | 0.020 |
Why?
|
| Dinoprost | 1 | 2007 | 22 | 0.020 |
Why?
|
| Muscle Contraction | 1 | 2007 | 66 | 0.020 |
Why?
|
| Catalase | 1 | 2007 | 109 | 0.020 |
Why?
|
| Superoxide Dismutase | 1 | 2007 | 155 | 0.020 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2007 | 130 | 0.020 |
Why?
|
| Models, Biological | 1 | 2010 | 677 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2010 | 517 | 0.020 |
Why?
|
| Hypoglycemic Agents | 1 | 2007 | 160 | 0.020 |
Why?
|
| Gene Expression | 1 | 2007 | 674 | 0.010 |
Why?
|
| Calcium | 1 | 2003 | 480 | 0.010 |
Why?
|